Prothena Plc Stock Analysis

Prothena Stock Analysis Notes

About 12.0% of the company outstanding shares are owned by corporate insiders. The book value of Prothena Plc was at this time reported as 9.35. The company has Price/Earnings To Growth (PEG) ratio of 0.8. Prothena plc recorded a loss per share of 3.21. The entity had not issued any dividends in recent years. Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company was founded in 2012 and is based in Dublin, Ireland. Prothena Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people. To find out more about Prothena plc contact the company at 353 1 236 2500 or learn more at https://www.prothena.com.

Prothena plc Investment Alerts

Prothena plc Upcoming and Recent Events

Prothena Largest EPS Surprises

View All Earnings Estimates

Prothena Plc Environmental, Social, and Governance (ESG) Scores

Prothena Stock Institutional Investors

Note, although Prothena Plc's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Prothena Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Prothena Plc's market, we take the total number of its shares issued and multiply it by Prothena Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Prothena Profitablity

The company has Profit Margin (PM) of (1.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Management Efficiency

Prothena plc has return on total asset (ROA) of (0.1981) % which means that it has lost $0.1981 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3107) %, meaning that it created substantial loss on money invested by shareholders. Prothena Plc's management efficiency ratios could be used to measure how well Prothena Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of May 13, 2024, Return On Tangible Assets is expected to decline to -0.21. The current year's Return On Capital Employed is expected to grow to -0.28. At present, Prothena Plc's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 42.3 M, whereas Total Assets are forecasted to decline to about 414.8 M.

Technical Drivers

As of the 13th of May 2024, Prothena Plc holds the Variance of 12.15, coefficient of variation of (1,276), and Risk Adjusted Performance of (0.04). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prothena Plc, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We were able to interpolate and analyze data for thirteen technical drivers for Prothena plc, which can be compared to its competitors. Please check Prothena plc market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Prothena plc is priced some-what accurately, providing market reflects its current price of 21.34 per share. Given that Prothena Plc has information ratio of (0.10), we recommend you to check out Prothena plc's recent market performance to make sure the company can sustain itself at a future point.

Prothena plc Price Movement Analysis

Prothena plc Insider Trading Activities

Prothena Plc Predictive Daily Indicators

Prothena Plc Corporate Filings

Prothena Plc Forecast Models

Prothena Plc's time-series forecasting models are one of many Prothena Plc's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Prothena Plc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Prothena Plc prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Prothena shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Prothena Plc. By using and applying Prothena Stock analysis, traders can create a robust methodology for identifying Prothena entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Prothena analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Prothena analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Prothena plc stock analysis indicators help investors evaluate how Prothena Plc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Prothena Plc shares will generate the highest return on investment. By understating and applying Prothena Plc stock analysis, traders can identify Prothena Plc position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

When running Prothena Plc's price analysis, check to measure Prothena Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prothena Plc is operating at the current time. Most of Prothena Plc's value examination focuses on studying past and present price action to predict the probability of Prothena Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prothena Plc's price. Additionally, you may evaluate how the addition of Prothena Plc to your portfolios can decrease your overall portfolio volatility.

Is Prothena Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.